NCT04159233

Brief Summary

This pilot study is focused on estimating the impact of a tele-sleep intervention on patient-centered outcomes relevant to former football players, including a) sleep duration, quality, and daytime impairment; b) pain, pain catastrophizing, physical and emotional functioning; c) mood; d) quality of life, with the longer-term goal to evaluate the impact on cardiovascular health risk. The evidence-based 'Brief Behavioral Therapy for Insomnia' (BBTI) will be utilized and tailored it to meet the needs of former football players. This pilot work will serve as the foundation for a larger, future clinical trial that utilizes a durable approach for improving sleep health with potential influence pain and quality of life as well as future studies to evaluate the implementation and scalability of BBTI in novel populations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 12, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

January 14, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2020

Completed
Last Updated

September 16, 2020

Status Verified

September 1, 2020

Enrollment Period

6 months

First QC Date

October 29, 2019

Last Update Submit

September 13, 2020

Conditions

Keywords

sleeppainprofessional athleteNational Football LeagueBehavioral intervention

Outcome Measures

Primary Outcomes (1)

  • Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance, 8b Endpoint

    PROMIS Sleep Disturbance measures self-reported sleep quality and associated daytime functioning during the past seven days. The measure includes 8-items with higher scores indicating greater sleep disturbance. The minimum score is 8 and the maximum score is 40. Item responses are combined to yield a T-score with a population mean of 50 and standard deviation of 10.

    Week 4

Secondary Outcomes (13)

  • PROMIS Sleep Disturbance, 8b Follow-up

    Week 12

  • PROMIS Sleep Impairment, 8a Endpoint

    Week 4

  • PROMIS Sleep Impairment, 8a Follow-up

    Week 12

  • Response to treatment (baseline to endpoint)

    Week 0 vs. Week 4

  • Response to treatment (baseline to follow-up)

    Week 0 vs. Week 12

  • +8 more secondary outcomes

Study Arms (1)

Adapted 'Brief Behavioral Therapy for Insomnia' (BBTI)

OTHER

All participants will receive the same intervention in this pilot study.

Behavioral: Brief Behavioral Therapy for Insomnia (BBTI)

Interventions

Participants will receive evidence-based 'Brief Behavioral Therapy for Insomnia' (BBTI), tailored to meet the needs of former football players. BBTi is a brief, efficacious treatment that focuses on modifying behaviors, rather than cognitive domains. The treatment emphasizes education, motivational tools, and specific behavioral recommendations (e.g., restricting time in bed) and will be administered through weekly phone calls with a trained sleep interventionist over 4-weeks.

Adapted 'Brief Behavioral Therapy for Insomnia' (BBTI)

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to communicate clearly in English
  • Have a digital device with reliable internet access
  • Sub-clinical insomnia (Insomnia Severity Index, score \>7, sub-clinical threshold insomnia)
  • Able to give informed consent

You may not qualify if:

  • Prior participation in behavioral therapy for insomnia
  • Self-reported circadian phase irregularity/delay, including regular shift work
  • Previously diagnosed Narcolepsy, bipolar disorder or other major psychiatric disorders
  • Active alcohol abuse (Alcohol Use Disorders Identification Test, AUDIT-C ≥4) or drug abuse (Drug Abuse Screening Test, DAST-2 ≥1)
  • Current severe major depressive disorder (Patient Health Questionnaire-8, PHQ-8, score ≥20)
  • Use of seizure medication or seizure within the past 10 years
  • Untreated, previously diagnosed moderate to severe sleep apnea or excessive daytime sleepiness (defined by Epworth sleepiness scale score ≥16) with a self-reported sleep duration (\>6 hours)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersPain

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Suzanne Bertisch, MD, MPH

    Assistant Professor in Medicine, Physician/Clinical Investigator

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 29, 2019

First Posted

November 12, 2019

Study Start

January 14, 2020

Primary Completion

June 30, 2020

Study Completion

September 7, 2020

Last Updated

September 16, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations